Kate Ingarfield

Reviewing the epidemiology of head and neck cancer: definitions, trends and risk factors

Mark Gormley, Grant Creaney, Andrew Schache et al. · BDJ · 2022 · 646 citations · Full text

Neck Cancer, Epidemiology Of Cancer, Neck Disorder +21

Fulvestrant plus capivasertib versus placebo after relapse or progression on an aromatase inhibitor in metastatic, oestrogen receptor-positive, HER2-negative breast cancer (FAKTION): overall survival, updated progression-free survival, and expanded biomarker analysis from a randomised, phase 2 trial

Sacha J. Howell, Angela Casbard, Margherita Carucci et al. · The Lancet Oncology · 2022 · 136 citations · Full text

Head and Neck Cancer: United Kingdom National Multidisciplinary Guidelines, Sixth Edition

Jarrod J. Homer, Stuart C. Winter, Elizabeth Abbey et al. · The Journal of Laryngology & Otology · 2024 · 45 citations · Full text

Neck Cancer, Sixth Edition, Medicine +14

<scp>Epstein‐Barr</scp> virus and human papillomavirus serum antibodies define the viral status of nasopharyngeal carcinoma in a low endemic country

Julia Simon, Lea Schroeder, Kate Ingarfield et al. · International Journal of Cancer · 2020 · 28 citations · Full text

Viral Diagnostics, Immunology, Pathology +18

HPV driven squamous cell head and neck cancer of unknown primary is likely to be HPV driven squamous cell oropharyngeal cancer

Lea Schroeder, Miranda Pring, Kate Ingarfield et al. · Oral Oncology · 2020 · 27 citations

Neck Cancer, Cervical Cancer, Human Papillomavirus Vaccines +15